Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes

Oncogenesis

Volumn 4, Issue 8, 2015, Pages

  Franzen, C A ^a   Blackwell, R H ^a   Todorovic, V ^b   Greco, K A ^a   Foreman, K E ^a   Flanigan, R C ^a   Kuo, P C ^a   Gupta, G N ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; BIOLOGICAL MARKER; CALVASCULIN; HEPARIN; MESSENGER RNA; PHOSPHATE BUFFERED SALINE; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; VIMENTIN;

ARTICLE; BLADDER; BLADDER CANCER CELL LINE; CELL INVASION; CELL ISOLATION; CELL MIGRATION; CELL MOTILITY; CONDITIONED MEDIUM; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXOSOME; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ULTRACENTRIFUGATION; URINE SAMPLING; UROTHELIAL CELL; UROTHELIUM;

EID: 84991017501     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2015.21     Document Type: Article

References (50)

1. Resnick MJ, Chang SS. Optimizing outcomes for octogenarians with invasive bladder cancer: one size does not fit all. Urol Oncol 2013; 31: 1-4.
2. Sylvester RJ. Natural history, recurrence, and progression in superficial bladder cancer. ScientificWorldJournal 2006; 6: 2617-2625.
3. Messing EM. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds). Campbell's Urology, 8th edn. Saunders: Philadelphia, PA, USA, 2002, pp 2750-2751.
4. Messing EM. Urothelial tumors of the bladder. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds). Campbell-Walsh's Urology. Saunders: Philadelphia, PA, USA, 2007, pp 17-2430.
5. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 2000; 113 (Pt 19): 3365-3374.
6. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010; 73: 1907-1920.
7. Raimondo F, Morosi L, Chinello C, Magni F, Pitto M. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics 2011; 11: 709-720.
8. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-659.
9. Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J et al. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics 2010; 9: 1324-1338.
10. Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Mol Cell Proteomics 2006; 5: 1760-1771.
11. Chen CL, Lai YF, Tang P, Chien KY, Yu JS, Tsai CH et al. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients. J Proteome Res 2012; 11: 5611-5629.
12. Jeppesen DK, Nawrocki A, Jensen SG, Thorsen K, Whitehead B, Howard KA et al. Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors. Proteomics 2014; 14: 699-712.
13. Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S et al. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ 2008; 15: 80-88.
14. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007; 67: 2912-2915.
15. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009; 284: 34211-34222.
16. Beckham CJ, Olsen J, Yin PN, Wu CH, Ting HJ, Hagen FK et al. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. J Urol 2014; 192: 583-592.
17. Yang L, Wu XH, Wang D, Luo CL, Chen LX. Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. Mol Med Rep 2013; 8: 1272-1278.
18. Blackwell RH, Franzen CA, Flanigan RC, Kuo PC, Gupta GN. The untapped potential of urine shed bladder cancer exosomes: biomarkers, signaling, and therapeutics. Bladder 2014; 1: e7.
19. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
20. Ramteke A, Ting H, Agarwal C, Mateen S, Somasagara R, Hussain A et al. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Mol Carcinog 2013; 54: 554-565.
21. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001; 98: 10356-10361.
22. Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M et al. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 2004; 10: 4125-4133.
23. Bates RC. Colorectal cancer progression: integrin alphavbeta6 and the epithelial-mesenchymal transition (EMT). Cell Cycle 2005; 4: 1350-1352.
24. Baumgart E, Cohen MS, Silva Neto B, Jacobs MA, Wotkowicz C, Rieger-Christ KM et al. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 2007; 13: 1685-1694.
25. Wu K, Zeng J, Zhou J, Fan J, Chen Y, Wang Z et al. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development. Urol Oncol 2013; 31: 1751-1760.
26. McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, Shah J et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 2009; 28: 335-344.
27. Yun SJ, Kim WJ. Role of the epithelial-mesenchymal transition in bladder cancer: from prognosis to therapeutic target. Korean J Urol 2013; 54: 645-650.
28. Bryan RT, Tselepis C. Cadherin switching and bladder cancer. J Urol 2010; 184: 423-431.
29. Fondrevelle ME, Kantelip B, Reiter RE, Chopin DK, Thiery JP, Monnien F et al. The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol Oncol 2009; 27: 268-276.
30. Paliwal P, Arora D, Mishra AK. Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale. Indian J Pathol Microbiol 2012; 55: 443-449.
31. Franzen CA, Simms PE, Van Huis AF, Foreman KE, Kuo PC, Gupta GN. Characterization of uptake and internalization of exosomes by bladder cancer cells. BioMed Res Int 2014; 2014: 619829.
32. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-428.
33. van der Horst G, Bos L, van der Pluijm G. Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma. Mol Cancer Res 2012; 10: 995-1009.
34. Daher N, Abourachid H, Bove N, Petit J, Burtin P. Collagen IV staining pattern in bladder carcinomas: relationship to prognosis. Br J Cancer 1987; 55: 665-671.
35. Mandeville JT, Lawson MA, Maxfield FR. Dynamic imaging of neutrophil migration in three dimensions: mechanical interactions between cells and matrix. J Leukoc Biol 1997; 61: 188-200.
36. Friedl P, Borgmann S, Brocker EB. Amoeboid leukocyte crawling through extracellular matrix: lessons from the Dictyostelium paradigm of cell movement. J Leukoc Biol 2001; 70: 491-509.
37. Wolf K, Muller R, Borgmann S, Brocker EB, Friedl P. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 2003; 102: 3262-3269.
38. Bijnsdorp IV, Geldof AA, Lavaei M, Piersma SR, van Moorselaar RJ, Jimenez CR. Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. J Extracell Vesicles 2013; 2: 1-10.
39. Kucharzewska P, Christianson HC, Welch JE, Svensson KJ, Fredlund E, Ringner M et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci USA 2013; 110: 7312-7317.
40. Christianson HC, Svensson KJ, van Kuppevelt TH, Li JP, Belting M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci USA 2013; 110: 17380-17385.
41. Wyckoff JB, Pinner SE, Gschmeissner S, Condeelis JS, Sahai E. ROCK-and myosindependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol 2006; 16: 1515-1523.
42. Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 2003; 5: 711-719.
43. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 2006; 7: 359-371.
44. Lau LF. CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci 2011; 68: 3149-3163.
45. Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007; 446: 1030-1037.
46. Franzen CA, Chen CC, Todorovic V, Juric V, Monzon RI, Lau LF. Matrix protein CCN1 is critical for prostate carcinoma cell proliferation and TRAIL-induced apoptosis. Mol Cancer Res 2009; 7: 1045-1055.
47. Song J, Zhang J, Wang J, Wang J, Guo X, Dong W. Beta1 integrin mediates colorectal cancer cell proliferation and migration through regulation of the Hedgehog pathway. Tumour Biol 2014; 36: 2013-2021.
48. Jiang X, Teng M, Guo X, Zhang D, Zhang Q, Zhang J et al. Switch from alphavbeta5 to alphavbeta6 integrin is required for CD9-regulated keratinocyte migration and MMP-9 activation. FEBS Lett 2014; 588: 4044-4052.
49. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996; 183: 1161-1172.
50. Moss NM, Wu YI, Liu Y, Munshi HG, Stack MS. Modulation of the membrane type 1 matrix metalloproteinase cytoplasmic tail enhances tumor cell invasion and proliferation in three-dimensional collagen matrices. J Biol Chem 2009; 284: 19791-19799.